As biopsy of metastases is affected by sampling bias and may miss this crucial intra-individual cancer heterogeneity (Mestel, 2017), HER2-directed hybrid imaging may identify a sub-group of patients in need for alternative treatment. This evidence concerns the gene ERBB2 and cancer.